Biotech · Private company
Neuraly, Inc.
Track this companyFree. Adds Neuraly, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- DD01Phase 2 · NAFLDClinicalTrials.gov · fetched Nov 12, 2026
- NLY01Phase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DD01Phase 1 · Overweight and ObesityClinicalTrials.gov · fetched Nov 12, 2026
- NLY01Phase 1 · Safety and Tolerability in Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASHPHASE2 · COMPLETED · started Jun 13, 2024ClinicalTrials.gov NCT06410924 · fetched Nov 12, 2026
- A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLDPHASE1 · COMPLETED · started Feb 24, 2021ClinicalTrials.gov NCT04812262 · fetched Nov 12, 2026
- A Clinical Study of NLY01 in Patient's With Early Parkinson's DiseasePHASE2 · COMPLETED · started Feb 27, 2020ClinicalTrials.gov NCT04154072 · fetched Nov 12, 2026
- A Phase 1 Study to Assess the Safety of NLY01 in Healthy SubjectsPHASE1 · COMPLETED · started Sep 19, 2018ClinicalTrials.gov NCT03672604 · fetched Nov 12, 2026